| Net Cash Provided by (Used in) Operating Activities |
$2,262,000 |
USD |
-11% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$21,000 |
USD |
-11% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$96,000 |
USD |
-37% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
6,937,338 |
shares |
0.81% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,379,000 |
USD |
-12% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$3,000 |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,098,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$4,564,000 |
USD |
12% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$45,000 |
USD |
-36% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$22,312,000 |
USD |
-1.8% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$679,000 |
USD |
-20% |
Q4 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$16,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$466,000 |
USD |
7.9% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$986,000 |
USD |
-7.2% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$23,000 |
USD |
360% |
Q1 2024 |
Q1 2024 |